Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Staurosporine

Staurosporine

pharmaceutical raw materials
Staurosporine structure

Staurosporine 

structure
  • CAS No:

    62996-74-1

  • Formula:

    C28H26N4O3

  • Chemical Name:

    Staurosporine

  • Synonyms:

    9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one,2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-,(9S,10R,11R,13R)-;9,13-Epoxy-1H,9H-diindolo[1,2,3-gh:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one,2,3,10,11,12,13-hexahydro-10-methoxy-9-methyl-11-(methylamino)-,[9S-(9α,10β,11β,13α)]-;(9S,10R,11R,13R)-2,3,10,11,12,13-Hexahydro-10-methoxy-9-methyl-11-(methylamino)-9,13-epoxy-1H,9H-diindolo[1,2,3-gh:3′,2′,1′-lm]pyrrolo[3,4-j][1,7]benzodiazonin-1-one;Antibiotic AM 2282;Staurosporine;Staurosporin;AM-2282;Alkaloid AM-2282 from Streptomyces;(+)-Staurosporine;Antibiotic 230;CGP 39360;109189-95-9

  • Categories:

    Pharmaceutical Intermediates  >  Antineoplastics

Description

Staurosporine is a potent and non-selective inhibitor of protein kinases with IC50s of 6 nM, 15 nM, 2 nM, and 3 nM for PKC, PKA, c-Fgr, and Phosphorylase kinase respectively.


An indolocarbazole that is a potent PROTEIN KINASE C inhibitor which enhances cAMP-mediated responses in human neuroblastoma cells. (Biochem Biophys Res Commun 1995;214(3):1114-20)

Staurosporine Basic Attributes

466.53

466.53

613-127-7

374128

DTXSID6041131

29419090

Characteristics

69.45000

5.07370

off-white powder

1.6±0.1 g/cm3

270°C

677.5ºC at 760 mmHg

363.6±31.5 °C

1.810

soluble in DMSO or ethanol.soluble in dimethyl sulfoxide , dimethyl formamide, ethyl acetate, hot acetone and ethanol. Slightly soluble in chloroform and methanol. Insoluble in water.

2-8°C

D25 +35.0° (c = 1 in methanol); D22 +56.1° (c = 0.14 in methanol)

Safety Information

3

UN 2811 6.1 / PGII

2

40-45-36/37/38-46

36/37-53-36-26-45

KD5084000

Xn,T,Xi

P201-P280-P308 + P313

H340-H350

|Danger|H228 (14.29%): Flammable solid [Danger Flammable solids]|P201, P202, P210, P240, P241, P260, P262, P264, P270, P273, P280, P281, P301+P310, P301+P312, P302+P350, P308+P313, P310, P314, P321, P322, P330, P361, P363, P370+P378, P391, P405, and P501|Aggregated GHS information provided by 7 companies from 6 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Drug Information

Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. (See all compounds classified as Enzyme Inhibitors.)

8,12-Epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-1-one, 2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-10-(methylamino)-, (8alpha,9beta,10beta,12alpha)-(+)-

Staurosporine Use and Manufacturing

Methods of Manufacturing

General procedure: A mixture of 2a (50 mg, 0.11 mmol), 4 (59 mg, 0.17 mmol), K2CO3 (46 mg, 0.33 mmol), and KI (55 mg, 0.33 mmol) in DMF (0.4 mL) was stirred at 80 C for 5 hr. To this mixture was added 4 (60 mg), K2CO3 (45 mg, 0.32 mmol), and KI (55 mg, 0.33 mmol) in DMF (0.2 mL) and the mixture was stirred at 80 C for 12 hr. The mixture was quenched with water and extracted with EtOAc. The organic layer was separated, washed with water and brine, dried over MgSO4 and concentrated in vacuo. The residue was purified by preparative HPLC. The desired fraction was neutralized with sat. NaHCO3 aq. and half of the solvent was evaporated and extracted with EtOAc. The organic layer was separated, washed with water and brine dried over MgSO4 and concentrated in vacuo to give 5a (60 mg, 0.082 mmol, 75 %) as a pale yellow amorphous solid.Under the protection of argon, in 100 ml two port in the reaction bottle, add 2.33 g cross spore alkali (5.0 mmol) for 50 ml tetrahydrofuran is dissolved, add 2 ml triethylamine, 0 C adding 1.3 g of di-T-butyl dicarbonate (6.0 mmol), 0 C reaction 30 min, water to terminate the reaction, methylene chloride extraction, anhydrous sodium sulfate concentrated after drying, silica gel column chromatography separation, dichloromethane: methanol (v/v 30:1) elute and get the 3' -N- Tert butoxycarbonyl cross spore alkali 2.18 g, yield 76%.

Uses

A protein Kinase C inhibitor that induces apoptosis in many cell types

Computed Properties

Molecular Weight:466.5
XLogP3:3.2
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:4
Rotatable Bond Count:2
Exact Mass:466.20049070
Monoisotopic Mass:466.20049070
Topological Polar Surface Area:69.4
Heavy Atom Count:35
Complexity:901
Undefined Atom Stereocenter Count:4
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes

Recommended Suppliers of Staurosporine

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.